YuQi

2022年獲證專利(2022 Issued)

Issue date Patent Title Patent No. 2022/1/4 Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine US11213495 2022/1/5 Opioid receptor modulators and use thereof MO J/005174 2022/1/5 Heterocyclic compounds and use thereof MO J/005468 2022/1/5 Heterodimeric Vascular Endothelia Growth Factor and Use Thereof EP3384029 2022/1/7 Heterocyclic compounds and use thereof …

2022年獲證專利(2022 Issued) Read More »

2023年獲證專利(2023 Issued)

獲證日 專利名稱 證號 2023/1/5 5-methoxytryptophan and its derivatives and uses thereof NZ733731 2023/1/10 Dipicolylamine derivatives and their pharmaceutical uses CA2949663 2023/1/13 Anti-Aβ antibodies and uses thereof JP7210612 2023/1/24 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease CA3109623 2023/1/27 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease HK40053325 …

2023年獲證專利(2023 Issued) Read More »

2023年獲證專利(2023 Issued)

Issue date Patent Title Patent No. 2023/1/5 5-methoxytryptophan and its derivatives and uses thereof NZ733731 2023/1/10 Dipicolylamine derivatives and their pharmaceutical uses CA2949663 2023/1/13 Anti-Aβ antibodies and uses thereof JP7210612 2023/1/24 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or Huntington’s disease CA3109623 2023/1/27 Benzimidazole compounds and use thereof for treating Alzheimer’s disease or …

2023年獲證專利(2023 Issued) Read More »

2022年獲證專利(2022 Issued)

獲證日 專利名稱 證號 2022/1/4 Method and composition for decreasing the psychotomimetic side effect and addictive disorder of ketamine US11213495 2022/1/5 Opioid receptor modulators and use thereof MO J/005174 2022/1/5 Heterocyclic compounds and use thereof MO J/005468 2022/1/5 Heterodimeric Vascular Endothelia Growth Factor and Use Thereof EP3384029 2022/1/7 Heterocyclic compounds and use thereof HK1238644 2022/1/19 Thiazolidinone …

2022年獲證專利(2022 Issued) Read More »

Spot Light of Recent Invention(2023/06/01)

DBPR117: A Precision Medicine (mAb) Targeting RSPO3/Wnt-Mediated Tumorigenesis Abstract:Click here PowerPoint:Click here Neuroprotective Agent DBPR168 against Chemotherapy-Induced Peripheral Neuropathy Abstract:Click here PowerPoint:Click here DBPR376- New Luteinizing Hormone-Releasing Hormone Receptor (LHRHR)-Targeting Small Molecule Mertansine Conjugate for Cancer Treatment Abstract:Click here PowerPoint:Click here DBPR728: An Aurora kinase inhibitor for precision targeting of MYC-amplified solid tumors (A precision …

Spot Light of Recent Invention(2023/06/01) Read More »